Gregory R. Beecher - Vice President, Chief Financial Officer and Treasurer
Analyst · Lehman Brothers
Thanks Mike and good morning everyone. Our third quarter sales of $299 million were up 4% from the prior quarter, while our non-GAAP earnings per diluted share totaled $0.17. Our GAAP earnings per diluted share totaled $0.22 and included the gain from the sales the broadband test divisions and other smaller specials which are being detailed in our press release. Total bookings of $273 million were down 11% with semiconductor tests bookings down 16% and the System Test Group up 18%. Please note that going forward, we will report two segments; Semiconductor Test and our System Test Group. With the latter made up of Mil/Aero test, commercial board test and automotive test. Semi test buying in the quarter was broad-based with the top 10 customers making up 51% of our third quarter bookings versus 58% in the prior quarter. 59% of our semi test orders came from IDMs and fabless companies and 41% from OSATs, this is versus 54% and 46% respectively than in prior quarter. There was improved demand in micro controller test and in some consumer segments. However, this buying was overshadowed by decreases in RF and automotive, which had strong second quarter bookings. Utilization levels were flat at IDMs, were up a few points at OSAT customers and are in the high 80s low 90s percentages. Before I go through the third quarter results and provide comments on the fourth quarter outlook, I would like to revise some summary commentary on 2007 against our longer term growth plan. First, I expect that 2007 will be a key year for us and that we will obtain market share and SOC test with FLEX and with J750 for the second year in a row. Over the past 18 months, we have won many design in that have grown our market share and increased our gross margins several points. In many of these gains, we have had a 30% or better cost of test improvement over the incumbent. This 30% plus advantage is critical to shifting market share at attractive gross margins. This is primarily due to the FLEX architectural advantages that enabled much more efficient parallel test. FLEX also covers a very wide range of devices, which plays particularly well with OSATs, who are clearly pushing their customers more than ever to select test providers who can offer a flexible platform. The OSATs are also increasing their share of test as IDMs look to outsource more. We expect the share gains from SOC test to continue and that these gains along with the continued focus on gross margins will get us to our model profitability rate of 15% operating income. This assumes a normal market size. Currently, we operate at about a 10% to 11% operating income rate assuming a $3 billion annual SOC test market. Of the four to five operating income points, we need to get to our model P&L, about one-third comes from manufacturing savings and the other two thirds comes from SOC test share gains. The manufacturing savings comes from moving board assembly, electro mechanical integration and final configuration and test for FLEX to the same outsource site in China. The savings should come in evenly over the next five or so quarters. Our first FLEX shipment from this single site was on August 8th, and now two-thirds of our FLEX shipments come from the single site. This transition is on schedule and requires very significant planning and oversight to pull off. We are unique in having this broader capability of board assembly to final configuration test in one low cost site. In addition to the obvious benefits of low material costs, this one site allows for more efficient manufacturing, less inventory and lower shipping cost. The other major initiatives to get us to our model is continued SOC test share gains. We need about 2 to 3 points of further SOC tests share gains to achieve our model P&L. Our trajectory of share gains over the past two years would suggest that this could occur over the next year or two. Now for modeling purposes each point of SOC test share gain improves our operating income rate by about one percentage point. You should also note that while the SOC test market size has averaged about $3 billion a year, it is ranged between $2.6 billion and $3.4 billion over the last four years. With this annual volatility, our operating income rate would be expected to increase or decrease by about a percentage point for each $100 million annual swing in the market size. While, progress on the model is clearly important we also recognize that the steady SOC test share gains are not enough to provide the necessary growth given the underlying growth rate in SOC test. So 2007 will also be important and that we are continuing to make the long term investments to access closely adjacent markets with differentiated products. These investments are quite significant both in a level of spending currently and by the amount to which they increased our available market over each of the next three years. So we are investing aggressively for the mid term while steadily growing and improving our profitability near in. Now let me take you through some of the details of the third quarter then our guidance for the fourth quarter of 2007. Our third quarter gross margin percentage was 48.2% of sales, up from 47.5% in the prior quarter due primarily to lower manufacturing costs and slightly higher sales. The product mix remains favorable as well. R&D expenses were flat at $52.2 million or 17.4% of sales compared to $52.4 million or 18.2% of sales in the second quarter. SG&A expenses were also flat at $62.9 million or 21% of sales as compared to $62.8 million or 21.7% of sales in the second quarter. Our net interest income was $7.7 million, down from $9.2 million in the prior quarter, due primarily to re-positioned our investment portfolio to shorter maturities, which caused a $2 million accounting loss due to the increase in interest rates, and also a lower average cash balance. We had $4.7 million of income tax expense in the quarter. Our quarter ending headcount was 36,000 employees. In past calls I have talked about our longer-term tax rates of about 26% to 28% once we eliminate our valuation allowance against our net deferred tax assets. Well, this remains our best estimate longer term. For next year 2008, we would expect to continue with a lower tax rate of about 15%. In our third quarter, semiconductor sales were 81% of the total and the System Test Group was 19%. On a geographic basis, our third quarter sales in descending percentage order broke down as follows. U.S. 19.3%, South East Asia 17.2%, Singapore 15.3%, Europe 12.9%, Korea 11.6%, Japan 10.6%, Taiwan 10.6% and rest of the world 2.5%. Our book-to-bill ratios for the third quarter were 0.91 for the over all Company. 0.89 for semiconductor test, 1.0 for the System Test Group. At the end of the quarter our backlog stood at $317.5 million of which 80% is schedule to ship within the next sixth months. On a geographic basis, our bookings for the quarter again in the descending percentage of order were distributed as follows. U.S. 22.5%, South East Asia 19.1%, Taiwan 15.2%, Singapore 13.5%, Europe 10.5%, Japan 9.5%, Korea 9.2%, and rest of the world 0.5%. Now moving to the balance sheet, we ended the third quarter with cash and marketable securities of $748 million. We used a $176 million of cash in the quarter to repurchase approximately 11.4 million of our shares at an average price of $15.38. Subsequent to quarter-end, we have repurchased approximately 4.2 million of our shares at an average price of $13.91, which completes our authorized share buyback program. In total, we have repurchased 27.9 million shares at an average price of $14.31 totaling $400 million. This program lowered our outstanding shares by 14%, leaving us with a balance of a 173.6 million shares outstanding. As we have just completed the authorized buyback, we will comment on our cash plans in our next conference call. In the third quarter, capital additions net of sales of related capital equipment were $12.6 million; depreciation and amortization for the third quarter was $22 million, including $5.6 million of stock-based compensation, accounts receivable stood at $231.6 million with 71 days sales outstanding. This is nine days above our model of 62 days. In short, the nine day increase is largely due to extended payment terms connected with some recent SOC test share gains. These extended terms are backed by letters of credit. We ended the quarter with product inventory of $91.1 million, up $3.8 million from the last quarter. In the fourth quarter of 2007 as Mike mentioned, we expect sales to be between $250 million and $275 million with diluted earnings per share between $0.04 and $0.10. We expect gross margins to be between 45% and 46%, R&D and SG&A expenses should be flat in dollars, but up in percentages to be between 19% and 21% and between 23% and 25% respectively. We expect it to be down about $10 million in inventory dollars and accounts receivable to be down also about $10 million. In addition, we expect to spend $18 million or less on capital. In the fourth quarter, our depreciation and amortization should be around $22 million including $5 million of stock-based comp. Our tax rate is expected to be about 10% in the fourth quarter. Now I will turn the call over to Tom.